CDNA - CareDX slide continues after jury awards $96.3M to Natera in patent dispute
2024-01-29 09:29:24 ET
More on CareDx
- CareDx's Turmoil: Risks Appear Priced In
- Circling Back On CareDx, Can The Rally Continue
- CareDx, Inc (CDNA) Q3 2023 Earnings Call Transcript
- CareDX drops after jury votes in favor of Natera in patent fight (update)
- CareDx sees FY24 revenue $279M-$280M above high end of guidance